NM_203486.3:c.1152G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_203486.3(DLL3):​c.1152G>A​(p.Ala384Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00269 in 1,543,398 control chromosomes in the GnomAD database, including 84 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A384A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.014 ( 41 hom., cov: 31)
Exomes 𝑓: 0.0014 ( 43 hom. )

Consequence

DLL3
NM_203486.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.565

Publications

1 publications found
Variant links:
Genes affected
DLL3 (HGNC:2909): (delta like canonical Notch ligand 3) This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
DLL3 Gene-Disease associations (from GenCC):
  • spondylocostal dysostosis 1, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive spondylocostal dysostosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 19-39507097-G-A is Benign according to our data. Variant chr19-39507097-G-A is described in ClinVar as Benign. ClinVar VariationId is 260773.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.565 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0142 (2157/152152) while in subpopulation AFR AF = 0.0487 (2022/41546). AF 95% confidence interval is 0.0469. There are 41 homozygotes in GnomAd4. There are 1021 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 41 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DLL3NM_203486.3 linkc.1152G>A p.Ala384Ala synonymous_variant Exon 7 of 9 ENST00000356433.10 NP_982353.1 Q9NYJ7-2
DLL3NM_016941.4 linkc.1152G>A p.Ala384Ala synonymous_variant Exon 7 of 8 NP_058637.1 Q9NYJ7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DLL3ENST00000356433.10 linkc.1152G>A p.Ala384Ala synonymous_variant Exon 7 of 9 2 NM_203486.3 ENSP00000348810.4 Q9NYJ7-2
DLL3ENST00000205143.4 linkc.1152G>A p.Ala384Ala synonymous_variant Exon 7 of 8 1 ENSP00000205143.3 Q9NYJ7-1
DLL3ENST00000596614.5 linkc.468G>A p.Ala156Ala synonymous_variant Exon 4 of 4 2 ENSP00000471688.1 M0R177

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2153
AN:
152038
Hom.:
41
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0487
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00303
AC:
434
AN:
143154
AF XY:
0.00254
show subpopulations
Gnomad AFR exome
AF:
0.0457
Gnomad AMR exome
AF:
0.00318
Gnomad ASJ exome
AF:
0.000122
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000249
Gnomad OTH exome
AF:
0.00167
GnomAD4 exome
AF:
0.00143
AC:
1993
AN:
1391246
Hom.:
43
Cov.:
31
AF XY:
0.00123
AC XY:
848
AN XY:
687682
show subpopulations
African (AFR)
AF:
0.0490
AC:
1563
AN:
31914
American (AMR)
AF:
0.00305
AC:
115
AN:
37682
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25166
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36372
South Asian (SAS)
AF:
0.0000875
AC:
7
AN:
79976
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33904
Middle Eastern (MID)
AF:
0.00274
AC:
12
AN:
4386
European-Non Finnish (NFE)
AF:
0.000108
AC:
117
AN:
1083854
Other (OTH)
AF:
0.00309
AC:
179
AN:
57992
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
109
218
327
436
545
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0142
AC:
2157
AN:
152152
Hom.:
41
Cov.:
31
AF XY:
0.0137
AC XY:
1021
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0487
AC:
2022
AN:
41546
American (AMR)
AF:
0.00589
AC:
90
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
67968
Other (OTH)
AF:
0.0113
AC:
24
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
106
212
318
424
530
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00301
Hom.:
1
Bravo
AF:
0.0159

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 31, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Spondylocostal dysostosis 1, autosomal recessive Benign:1
Nov 28, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
8.0
DANN
Benign
0.92
PhyloP100
-0.56
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115456333; hg19: chr19-39997737; API